Followers | 5 |
Posts | 973 |
Boards Moderated | 0 |
Alias Born | 03/03/2011 |
Thursday, August 04, 2011 4:39:01 PM
even if 3rd entrant comes to market, say they burn cash on 20m/year...you still don't need 350m of cash to get to 2014 copaxone launch - which they keep saying they are 100% positive. they only need another 60m. Why don't you put your 250m-300m to work either in accelerating your FOB work or in buying back shares ?
if you model the earnings of this company in 2 years to be very conservatively lovenox(with TL - 0m-pays expenses) and copaxone(120m) (excluding hidden goldmine of FOB characterization technology), your earnings would be approx >$2 per share..based on current price that is p/e of 8.5 or in other words a rate of return of 11.7%.
why then would you settle for keeping cash in bank at 1% return when you conservatively have potential of earning 11.7% return if you buy back shares ??
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM